Investing
Rite Aid, DexCom Plunge into Thursday's 52-Week Low Club
Published:
Last Updated:
September 28, 2017: Here are four stocks trading with heavy volume among 41 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by more than 4 to 3 and on the Nasdaq advancers led decliners by about the same ratio.
Rite Aid Corp. (NYSE: RAD) dropped by 11.8% Thursday to establish a new 52-week low of $2.01 after closing at $2.28 on Wednesday. The 52-week high is $8.77. Volume of around 59 million shares traded was approaching double the daily average. The company reported weak sales this morning.
DexCom Inc. (NASDAQ: DXCM) posted a new 52-week low of $42.62 on Thursday, down about 37% from Wednesday’s closing price of $67.47. The stock’s 52-week high is $89.98. Volume totaled around 27 million shares, more than 25 times the daily average. The company’s stock tumbled following FDA approval of a blood-sugar monitoring system made by rival Abbott.
Uniti Group Inc. (NASDAQ: UNIT) dropped about 2.3% Thursday to post a new 52-week low of $13.81 after closing at $14.13 on Wednesday. The 52-week high is $32.06. Volume was around 7.2 million, nearly 3 times the daily average. The company had no specific news.
SCANA Corp. (NYSE: SCG) dropped about 3.6% Thursday to post a new 52-week low of $49.37 after closing at $51.22 on Wednesday. The stock’s 52-week high is $74.99. Volume of around 3.6 million was nearly triple the daily average. The company was hit with a lawsuit late Wednesday accusing executives of misleading investors about progress on two new nuclear power generation plants it was building.
Robinhood set out to democratize investing to individuals, and it’s not slowing down. The app makes it possible to buy and sell stocks, mutual funds, trade options, and even cryptocurrencies like Bitcoin (BTC) and Ethereum (ETH).
With FDIC insurance ,an award winning design, and benefits like IRAs and more, Robinhood could be your path to a richer tomorrow.
Sign up today — click here to start your journey.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.